| __timestamp | Cytokinetics, Incorporated | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 1213000 |
| Thursday, January 1, 2015 | 19667000 | 3425000 |
| Friday, January 1, 2016 | 27823000 | 6311000 |
| Sunday, January 1, 2017 | 36468000 | 9518000 |
| Monday, January 1, 2018 | 31282000 | 28080000 |
| Tuesday, January 1, 2019 | 39610000 | 36550000 |
| Wednesday, January 1, 2020 | 52820000 | 46125000 |
| Friday, January 1, 2021 | 96803000 | 68486000 |
| Saturday, January 1, 2022 | 177977000 | 92032000 |
| Sunday, January 1, 2023 | 173612000 | 117532000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Cytokinetics, Incorporated and Rhythm Pharmaceuticals, Inc. over a decade, from 2014 to 2023. Cytokinetics has seen a staggering increase in SG&A expenses, growing by over 900% from 2014 to 2022, peaking at approximately $178 million in 2022. Meanwhile, Rhythm Pharmaceuticals, although starting with lower expenses, has also experienced significant growth, with a nearly 100-fold increase, reaching around $117 million in 2023. This trend highlights the escalating costs associated with scaling operations and advancing drug development. As both companies continue to innovate, understanding these financial dynamics offers valuable insights into their strategic priorities and market positioning.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Rhythm Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Teva Pharmaceutical Industries Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared